In the last trading session, 1.42 million shares of the Cogent Biosciences Inc (NASDAQ:COGT) were traded, and its beta was 2.01. Most recently the company’s share price was $4.58, and it changed around $0.32 or 7.51% from the last close, which brings the market valuation of the company to $521.43M. COGT currently trades at a discount to its 52-week high of $12.61, offering almost -175.33% off that amount. The share price’s 52-week low was $3.72, which indicates that the current value has risen by an impressive 18.78% since then. We note from Cogent Biosciences Inc’s average daily trading volume that its 10-day average is 1.8 million shares, with the 3-month average coming to 1.46 million.
Cogent Biosciences Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.50. If we narrow it down even further, the data shows that 0 out of 11 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 3 recommended COGT as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight. Cogent Biosciences Inc is expected to report earnings per share of -0.58 for the current quarter.
Cogent Biosciences Inc (NASDAQ:COGT) trade information
Instantly COGT has showed a green trend with a performance of 7.51% at the end of last trading. The rise to weekly highs of 5.11 on recent trading dayincreased the stock’s daily price by 10.37%. On the other hand, Cogent Biosciences Inc (NASDAQ:COGT) is -35.85% down in the 30-day period. We can see from the shorts that 13.0 million shares have been sold at a short interest cover period of 10.97 day(s).
The consensus price target as assigned by Wall Street analysts is $14, which translates to bulls needing to increase their stock price by 67.29% from its current value. Analyst projections state that COGT is forecast to be at a low of $14 and a high of $14.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 10.02%. Cogent Biosciences Inc earnings are expected to increase by 9.38% in 2025, but the outlook is positive 31.60% per year for the next five years.
COGT Dividends
Cogent Biosciences Inc’s next quarterly earnings report is expected to be released on 2025-Feb-24.
Cogent Biosciences Inc (NASDAQ:COGT)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.16% of Cogent Biosciences Inc shares, and 108.09% of them are in the hands of institutional investors. The stock currently has a share float of 108.26%. Cogent Biosciences Inc stock is held by 232.0 institutions, with POINT72 ASSET MANAGEMENT, L.P. being the largest institutional investor. By 2024-06-30, it held 10.5506% of the shares, which is about 10.47 million shares worth $88.27 million.
COMMODORE CAPITAL LP, with 9.8126% or 9.74 million shares worth $82.09 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Fidelity Securities Fund-Fidelity Small Cap Growth Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 3.29 shares worth $15.07 million, making up 2.89% of all outstanding shares. On the other hand, Fidelity Securities Fund-Fidelity Small Cap Growth Fund held roughly 2.58 shares worth around $11.81 million, which represents about 2.27% of the total shares outstanding.
